A multisite trial comparing two cytomegalovirus (CMV) pp65 antigenemia test kits, biotest CMV brite and Bartels/Argene CMV antigenemia

Journal of Clinical Microbiology

Volumn 38, Issue 4, 2000, Pages 1430-1433

  St George, Kirsten ^a   Boyd, Molly J ^b   Lipson, Steven M ^c   Ferguson, David ^d   Cartmell, G Frank ^b   Falk, Leon H ^c   Rinaldo, Charles R ^a   Landry, Marie L ^d  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b INTEGRIS BAPTIST MEDICAL CENTER   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIUM CULTURE; BACTERIUM DETECTION; CELL COUNT; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DIAGNOSTIC VALUE; HUMAN; INTERMETHOD COMPARISON; NONHUMAN; PRIORITY JOURNAL;

BACTERIA (MICROORGANISMS); CUCUMBER MOSAIC VIRUS; CYTOMEGALOVIRUS; DNA VIRUSES; HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0033997494     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.38.4.1430-1433.2000     Document Type: Article

References (12)

1. Boeckh, M., T. A. Gooley, D. Myerson, T. Cunningham, G. Schoch, and R. A. Bowden. 1996. Cytomegalovirus pp65 antigenemia-guided early treatment with ganciclovir at engraftment after allogeneic marrow transplantation: a randomized double-blind study. Blood 88:4063-4071.
2. Einsele, H., G. Ehninger, H. Hebart, K. M. Wittkowski, U. Schuller, G. Jahn, P. Mackes, M. Herter, T. Klingebiel, J. Loffler, S. Wagner, and C. A. Muller. 1995. Polymerase chain reaction monitoring reduces the incidence of cytomegalovirus disease and the duration of side effects of antiviral therapy after hone marrow transplantation. Blood 86:2815-2820.
3. Gerna, G., G. Revello, E. Percivalle, and F. Morini. 1992 Comparison of different immunostaining techniques and monoclonal antibodies to the lower matrix phosphoprotein (pp65) for optimal quantitation of human cytomegalovirus antigenemia. J. Clin. Microbiol. 30:1232-1237.
4. Grossi, P., S. Kusne, C. Rinaldo, K. St. George, M. Magnone, J. Rakela, J. Fung, and T. E. Starzl. 1996. Guidance of ganciclovir therapy with pp65 antigenemia in cytomegalovirus-free recipients of livers from seropositive donors. Transplantation 61:1659-1660.
5. Hsiung, G. D., C. K. Y. Fong, and M. L. Landry. 1994. Hsiung's diagnostic virology, 4th ed. Yale University Press, New Haven, Conn.
6. Kutza, A. S. T., E. Muhl, H. Hackstein, H. Kirchner, and G. Bein. 1998. High incidence of active cytomegalovirus infection among septic patients. Clin. Infect. Dis. 26:1076-1082.
7. Landry, M. L., and D. Ferguson. 1993. Comparison of quantitative cytomegalovirus antigenemia with culture methods and correlation with clinical disease. J. Clin. Microbiol. 31:2851-2856.
8. Landry, M. L., D. Ferguson, S. Cohen, K. Huber, and P. Wetherill. 1995. Effect of delayed specimen processing on cytomegalovirus antigenemia test results. J. Clin. Microbiol. 33:257-259.
9. Lipson, S. M., M. E. Match, A. I. Toro, M. H. Kaplan, and D. H. Shepp. 1998. Application of a standardized cytomegalovirus antigenemia assay in the management of patients with AIDS. Diagn. Microbiol. Infect. Dis. 32:75-79.
10. St. George, K., and C. R. Rinaldo, Jr. 1997. Comparison of commercially available antibody reagents for the cytomegalovirus pp65 antigenemia assay. Clin. Diagn. Virol. 7:147-152.
11. St. George, K., and C. R. Rinaldo, Jr. 1999. Comparison of cytomegalovirus antigenemia and culture assays in patients on and off antiviral therapy. J. Med. Virol. 59:91-97.
12. van der Bij, W., J. Schirm, R. Torensma, W. J. van Son, A. M. Tegzess, and T. H. The. 1988. Comparison between viremia and antigenemia for detection of cytomegalovirus in blood J. Clin. Microbiol. 26:2531-2535.